Published November 15, 2013 | Version v1
Journal article

The LMNA mutation p.Arg321Ter associated with dilated cardiomyopathy leads to reduced expression and a skewed ratio of lamin A and lamin C proteins

  • 1. Research Unit for Molecular Medicine, Aarhus University and Aarhus University Hospital, Aarhus (Denmark)
  • 2. Department of Cardiology, Aarhus University Hospital, Aarhus (Denmark)
  • 3. Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus (Denmark)
  • 4. Heart Failure Research Center, Academic Medical Center, Amsterdam (Netherlands)
  • 5. Department of Forensic Medicine, Bioanalytical Unit, University of Aarhus (Denmark)
  • 6. Department of Molecular Biology and Genetics, University of Aarhus (Denmark)
  • 7. Department of Cardiology, Odense University Hospital, Odense (Denmark)

Description

Dilated cardiomyopathy (DCM) is a disease of the heart muscle characterized by cardiac chamber enlargement and reduced systolic function of the left ventricle. Mutations in the LMNA gene represent the most frequent known genetic cause of DCM associated with disease of the conduction systems. The LMNA gene generates two major transcripts encoding the nuclear lamina major components lamin A and lamin C by alternative splicing. Both haploinsuffiency and dominant negative effects have been proposed as disease mechanism for premature termination codon (PTC) mutations in LMNA. These mechanisms however are still not clearly established. In this study, we used a representative LMNA nonsense mutation, p.Arg321Ter, to shed light on the molecular disease mechanisms. Cultured fibroblasts from three DCM patients carrying this mutation were analyzed. Quantitative reverse transcriptase PCR and sequencing of these PCR products indicated that transcripts from the mutant allele were degraded by the nonsense-mediated mRNA decay (NMD) mechanism. The fact that no truncated mutant protein was detectable in western blot (WB) analysis strengthens the notion that the mutant transcript is efficiently degraded. Furthermore, WB analysis showed that the expression of lamin C protein was reduced by the expected approximately 50%. Clearly decreased lamin A and lamin C levels were also observed by immunofluorescence microscopy analysis. However, results from both WB and nano-liquid chromatography/mass spectrometry demonstrated that the levels of lamin A protein were more reduced suggesting an effect on expression of lamin A from the wild type allele. PCR analysis of the ratio of lamin A to lamin C transcripts showed unchanged relative amounts of lamin A transcript suggesting that the effect on the wild type allele was operative at the protein level. Immunofluorescence microscopy analysis showed no abnormal nuclear morphology of patient fibroblast cells. Based on these data, we propose that heterozygosity for the nonsense mutation causes NMD degradation of the mutant transcripts blocking expression of the truncated mutant protein and an additional trans effect on lamin A protein levels expressed from the wild type allele. We discuss the possibility that skewing of the lamin A to lamin C ratio may contribute to ensuing processes that destabilize cardiomyocytes and trigger cardiomyopathy - Highlights: • We study disease mechanisms in DCM patients carrying PTC mutations in the LMNA gene. • The mutant transcript is degraded by the nonsense mediated mRNA decay system. • Skewed lamin A to lamin C protein ratio expressed from the wild type allele. • We suggest a combined pathomechanism: haploinsuffiency plus lamin A/C imbalance

Availability note (English)

Available from http://dx.doi.org/10.1016/j.yexcr.2013.08.024

Additional details

Identifiers

DOI
10.1016/j.yexcr.2013.08.024;
PII
S0014-4827(13)00367-4;

Publishing Information

Journal Title
Experimental Cell Research
Journal Volume
319
Journal Issue
19
Journal Page Range
p. 3010-3019
ISSN
0014-4827
CODEN
ECREAL

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
45099548
Subject category
S60: APPLIED LIFE SCIENCES;
Descriptors DEI
DISEASES; FIBROBLASTS; HEART; MESSENGER-RNA; MUTATIONS; POLYMERASE CHAIN REACTION; PROTEINS; SPLICING
Descriptors DEC
ANIMAL CELLS; BODY; CARDIOVASCULAR SYSTEM; CONNECTIVE TISSUE CELLS; GENE AMPLIFICATION; NUCLEIC ACIDS; ORGANIC COMPOUNDS; ORGANS; RNA; RNA PROCESSING; SOMATIC CELLS

Optional Information

Copyright
Copyright (c) 2013 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.